An interagency agreement between the CIA and Anthony Fauci's division at the National Institutes of Health shows the spy agency funneled funds into civilian virus research, a collaboration that operated for years with virtually no public oversight.
The undated agreement, obtained by the Daily Caller News Foundation, describes a formal partnership between the CIA's Biological Technology Center and the National Institute of Allergy and Infectious Diseases. Under the arrangement, the CIA initiated collaboration with NIAID on what the documents call "forensic microbiology", work focused on bioterrorism pathogens for the intelligence community. CIA funds would be used to leverage pre-existing civilian research at NIAID and a private nonprofit genome lab located just outside NIH headquarters in Rockville, Maryland.
The documents add a new dimension to the growing body of evidence that Fauci's agency served as far more than a public health institution during the post-9/11 era. They land as Sen. Rand Paul continues to press Fauci on his agency's entanglement with the intelligence community, an investigation that has already produced Fauci's private diary entries from the early 2000s and sworn testimony from a former CIA officer.
The interagency agreement names the CIA's Biological Technology Center, a sub-unit of the agency's Advanced Technologies and Programs division, as the initiating party. Its partner on the NIAID side was the Intelligence Technology Innovation Center. A third entity, the Institute for Genomic Research, or TIGR, a private nonprofit now called the J. Craig Venter Institute, also appears as a collaborator.
TIGR sat in Rockville, Maryland, just outside NIH headquarters. The agreement states that TIGR "has also sought to foster a specific capability in forensic microbiology by building a partnership with REDACTED." The identity of that intelligence-community partner remains blacked out. The document adds that "the collaborative efforts between TIGR and REDACTED are producing a research program in Integrated Bio-threat Forensics-Systems Biology," and that "to date no such collaborative efforts exist anywhere at the REDACTED level with this specific goal."
Unclassified basic research on viruses, the agreement states, "will be used to augment and complement" CIA research and development. The CIA described itself as "leveraging partnerships across government agencies wherever possible to support and further develop robust forensic microbiology capability." The agency would study complete viruses rather than one gene at a time, and would help NIAID obtain the germs.
Work produced under the partnership was designated sensitive but not classified. Even so, the CIA retained the right to approve any sharing of data before it left the collaboration. That restriction meant civilian researchers working under the agreement operated under intelligence-community information controls without formal classification.
The CIA-NIAID arrangement grew out of a broader government mobilization after the September 2001 anthrax attacks. Fauci collaborated with President George W. Bush to remake NIAID from a conventional infectious-disease agency into a biodefense research hub. In January 2003, Bush used his State of the Union address to ask Congress to surge funding for defense against biological weapons. That money flowed heavily into Fauci's department at NIH.
Rutgers chemistry professor Richard Ebright, a longtime critic of NIAID's biodefense pivot, reviewed the documents and offered a blunt assessment. He said Vice President Dick Cheney assigned Fauci to head U.S. biodefense research programs in 2002:
"Vice President Cheney assigned Fauci to head US biodefense research programs in 2002, including bioweapons-agents-development and bioweapons-agents-characterization research programs that approached, and arguably crossed, red lines set by the Biological Weapons Convention. The documents show early steps in the process of transferring funding for, and direction of, CIA and DoD biodefense projects to Fauci's agency, NIAID."
If Ebright's characterization is accurate, the arrangement did not simply fund defensive research. It placed Fauci's civilian agency at the center of work that edged toward the legal boundaries governing biological weapons, boundaries set by an international treaty the United States signed in 1972.
The same year Bush pushed for biodefense funding, the U.S. invaded Iraq in March 2003 citing intelligence assessments about nuclear and biological weapons. By April 2003, NIH had finished mapping the entire human genome, a scientific milestone that made advanced pathogen research far more accessible and far harder for intelligence agencies to monitor.
A separate CIA memo from November 2003, titled "The Darker Bioweapons Future," laid out the strategic logic behind the push into civilian labs. The memo, highlighted by Sen. Paul's team, warned that detecting biological weapons was far harder than detecting nuclear weapons. Building a nuclear bomb requires resource-intensive uranium enrichment that rivals can spot. Biological threats, by contrast, were advancing so rapidly that traditional intelligence methods could not keep pace.
A group from the National Academy of Sciences told the CIA that intelligence agencies needed more assets embedded in biology labs around the world. One National Academy member went further, suggesting that scientists form a "living sensor web" to collect intelligence from foreign colleagues at conferences and university laboratories.
The memo noted that academics had gotten over their Vietnam-era skepticism of the national security establishment and "would be more open to collaboration." That line captures the essential bargain: the CIA needed access to civilian science, and civilian scientists were willing to provide it. What the memo did not address was who would watch the resulting partnerships, or whether anyone would.
Fauci, who has faced mounting legal and investigative pressure in recent years, did not respond to a request for comment from the Daily Caller News Foundation. The CIA also did not respond. The J. Craig Venter Institute, TIGR's successor, likewise declined to comment.
Jim Erdman, a former CIA Senior Operations Officer and former member of a declassification task force under former Director of National Intelligence Tulsi Gabbard, provided written testimony to Paul's committee describing what grew out of the early-2000s arrangements. His account paints a picture of an interconnected web of government agencies, academic researchers, and foreign partners that operated for more than twenty years with no meaningful accountability structure.
Erdman told the committee:
"They received funding from NIAID and other agencies for vaccine research, USAID's PREDICT project, the [Pentagon's] cooperative threat reduction program, and even worked with Chinese scientists on coronavirus and other pathogen studies pursuing vaccines. There was no oversight monitoring how this web of relationships influenced research, policy, and public health in any holistic way for over 20 years."
That testimony puts names on the funding streams: NIAID, USAID, and the Pentagon's cooperative threat reduction program. It also identifies the participants, including Chinese scientists working on coronavirus and other pathogen studies. And it identifies the gap: no one was watching how these relationships shaped research priorities, public health policy, or national security.
Erdman's summary judgment was pointed: "The lines between public health and biodefense have been blurred beyond recognition ever since."
A separate CIA whistleblower, it is unclear from available reporting whether this is the same individual as Erdman or a different person, told Paul's committee in written testimony that biology work undertaken on behalf of U.S. intelligence "incentivized dangerous research at U.S. labs and abroad." That claim, if substantiated, would mean the CIA-NIAID collaboration did not merely fund existing science but actively pushed researchers toward riskier work.
One name in the constellation of researchers connected to these programs is Ralph Baric, a coronavirologist who collaborated on coronavirus engineering experiments with the Wuhan Institute of Virology. Baric also served as an adviser to the intelligence community through the Biological Sciences Expert Group. He received funding from NIAID and other agencies, according to Erdman's testimony. Baric recently retired from the University of North Carolina and could not be reached for comment.
The link between NIAID-funded researchers and the Wuhan lab has been a central thread in the ongoing debate over COVID-19's origins. Even Biden's former COVID czar has acknowledged that a lab leak is the more likely explanation for the pandemic's start. The newly obtained documents do not resolve that question, but they fill in a piece of the institutional architecture that made such collaborations possible, and that kept them hidden from public view.
Sen. Paul pressed Fauci directly on whether the CIA ever transferred funds to NIH or conducted research with any intelligence agency at a high-profile hearing on July 29. Fauci's repeated invocations of the Fifth Amendment during congressional testimony have only deepened suspicion that the full scope of these arrangements remains concealed.
Several features of the interagency agreement stand out for what they reveal about information control. The work was not classified, a designation that would have triggered specific congressional notification and oversight requirements. Instead, it was labeled "sensitive," a lower category that kept it out of the formal classified-program oversight structure while still restricting who could see the results.
The CIA retained approval authority over any sharing of data produced under the agreement. That gave the intelligence community effective veto power over what civilian researchers could publish or disclose, without the accountability mechanisms that attach to classified programs. It was a workaround: intelligence-community control without intelligence-community oversight.
The agreement itself is undated, which means the public cannot determine when the partnership began, how long it lasted, or whether it was renewed. Key sections remain redacted, including the identity of at least one intelligence-community partner that collaborated with TIGR. These gaps are not incidental. They are structural features of a system designed to keep the collaboration's full dimensions out of public view.
The Senate committee's contempt proceedings against Fauci reflect the frustration of lawmakers who believe they have been stonewalled at every turn. Each new document release raises the same question: what else remains hidden?
For more than two decades, the CIA embedded itself in America's civilian public health infrastructure, used taxpayer-funded research for intelligence purposes, and ensured that no one outside the arrangement could see what was produced. The people who built that system owe the public a full accounting, and the silence from Fauci, the CIA, and every other party involved suggests they know it.
